NICE Ltd NICE 深 滬
等待開盤 08-21 09:30:00 美东时间
100.37
-0.560
-0.55%
華盛通- 最 高101.4997
- 今 開99.64
- 成交量 31.95万股
- 最 低 99.49
- 昨 收 100.93
- 總市值 596.23万
- 52周最高 153.68
- 市盈率 靜 10.30
- 換手率 0.54%
- 52周最低 83.10
- 委 比 -79.82%
- 總股本 5.94万
- 歷史最高 319.88
- 量 比 0.59
- 振 幅 1.99%
- 歷史最低 25.855
- 每 手 1
- 風險率 17.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
DA Davidson Maintains Buy on NICE, Raises Price Target to $115
DA Davidson analyst Clark Wright maintains NICE (NASDAQ:NICE) with a Buy and raises the price target from $110 to $115.
08-07 06:12
NICE Raises FY2026 Adj EPS Guidance from $10.98-$11.18 to $11.06-$11.26 vs $11.10 Est; Affirms FY2026 Sales Guidance of $3.170B-$3.190B vs $3.179B Est
NICE (NASDAQ:NICE) raises FY2026 Adj EPS guidance from $10.98-$11.18 to $11.06-$11.26 vs $11.10 analyst estimate. Affirms FY2026 sales outlook from $3.170 billion-$3.190 billion to $3.170 billion-$3.190 billion vs $3.179 billion estimate.
08-05 19:24
NICE Q2 Adj. EPS $2.70 Beats $2.64 Estimate, Sales $782.293M Beat $766.507M Estimate
NICE (NASDAQ:NICE) reported quarterly earnings of $2.70 per share which beat the analyst consensus estimate of $2.64 by 2.27 percent. This is a 10.3 percent decrease over earnings of $3.01 per share from the same period last year. The company reported quarterly sales of $782.293 million which beat t...
08-05 17:30
NiCE Expands Collaboration With RingCentral For NiCE To Resell RingCentral's Unified Communications As A Service Solution RingEXTM
NiCE (NASDAQ:NICE) today announced a significant expansion of its long-standing partnership with RingCentral, Inc. (NYSE:RNG), a global leader in AI-powered customer engagement. Under a new multi-year agreement, NiCE will resell RingCentral's unified communications as a service (UCaaS) solution, Rin...
07-24 04:04
美股大行评级 | 富国银行上调亚马逊目标价从313美元升至322美元；潜在涨幅370.99%！HC Wainwright上调Greenwich LifeSciences目标价至69美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Greenwich LifeSciences"买入"评级，目标价从50美元升至69美元；高盛：维持Taysha Gene Therapies"买入"评级，目标价从11美元升至13美元
07-22 11:35
Morgan Stanley Downgrades NICE to Equal-Weight, Lowers Price Target to $111
Morgan Stanley analyst Elizabeth Porter downgrades NICE (NASDAQ:NICE) from Overweight to Equal-Weight and lowers the price target from $130 to $111.
07-21 19:53
Bell Integration will join NiCE 1-2 July 2026 at NiCE World London
Let's Talk about Reshaping your CX with AI LONDON, June 30, 2026 /PRNewswire/ -- Bell Integration today proudly announced its role as a Gold Partner and Gold Sponsor of NiCE World London, ...
06-30 12:03
美股夜盘 | Viridian Therapeutics, Inc.涨6.65%，Bloom Energy涨6.32%
Viridian Therapeutics, Inc.涨6.65%；Bloom Energy涨6.32%；ACM Research, Inc. Class A涨5.61%
06-29 15:01
美股夜盘 | Viridian Therapeutics, Inc.涨8.16%，AbCellera Biologics, Inc.涨7.45%
Viridian Therapeutics, Inc.涨8.16%；AbCellera Biologics, Inc.涨7.45%；AEVEX Corp. Class A涨4.36%
06-29 13:01
